Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

Accueil Connaissances Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

The aim of this study was to compare the humoral immune response provided by four commercialised reproductive vaccines against swine erysipelas (SE) and porcine parvovirus (PPV), under field conditions in Denmark. 

À propos de cet article

Paru dans

European Symposium of Porcine Health Management, 2018

Date

10 juil. 2018

Auteurs

Pedersen, K.S.; Camprodon, A.; Llopart, D.; Jorda, R.; Strunz, A.M.

Résumé

Gilts vaccinated with ERYSENG® PARVO exhibited the highest serological response compared with animals vaccinated with one of the other three commercialised vaccines against E. rhusiopathiae.

Produits liés

Partager